What Comorbidities Should COPD Checkups Screen For?
At a Glance
People with COPD should have symptom- and risk-based checkups for heart disease, bone thinning and muscle loss, anxiety or depression, sleep apnea, lung cancer, and pulmonary hypertension. Not everyone needs every test; the right evaluation depends on individual findings.
In this answer
7 sections
COPD doesn’t exist in a vacuum; it often occurs alongside other health conditions—called comorbidities—that can worsen breathlessness, reduce your ability to function, and impact your overall health [1]. Routine checkups involve a structured review that screens for cardiovascular disease, bone and muscle loss, anxiety and depression, sleep apnea, and lung cancer [1][2]. Screening primarily means discussing your symptoms, risks, and doing a physical exam. It does not mean every patient needs a battery of tests. Tests like an ECG, echocardiogram, DXA scan, sleep study, or right-heart catheterization are not automatically needed for everyone and are ordered only when symptoms or risks point to them.
When to Seek Urgent Care
Routine checkups are for stable symptoms. Seek immediate emergency care if you experience sudden or severe breathlessness, chest pressure or pain, fainting, confusion, blue or gray lips, or if you are coughing up blood. Contact your doctor for same-day advice if you have rapidly worsening leg swelling (especially if it is one-sided), a fever, or a clear, sudden worsening of your usual COPD symptoms. Never wait for a scheduled checkup if you are experiencing an emergency.
Cardiovascular Disease and Heart Failure
Because conditions like heart failure and coronary artery disease share symptoms with COPD—such as shortness of breath, fatigue, and exercise intolerance—they can be difficult to distinguish [3]. Your doctor will regularly assess your blood pressure and overall cardiovascular risk [4]. If you experience frequent COPD flare-ups, chest pain, palpitations, or shortness of breath that seems out of proportion to your lung disease, your doctor may order targeted tests [5]. These can include an electrocardiogram (ECG) to check the electrical activity of your heart, a blood test for heart strain (BNP or NT-proBNP), or an ultrasound of your heart (echocardiogram) to estimate how well it pumps [6][3].
Bone and Muscle Loss (Osteoporosis and Sarcopenia)
People with COPD are at higher risk for bone thinning (osteoporosis) and muscle loss (sarcopenia). Bone risk increases heavily with smoking, inactivity, lower body weight, and the long-term use of oral corticosteroid pills (inhaled corticosteroids carry a different, dose-dependent risk profile) [7]. A DXA scan is a specialized X-ray primarily used to measure bone mineral density and assess your fracture risk [7].
However, a standard DXA scan does not diagnose sarcopenia or assess your risk of falling. To evaluate muscle function and frailty (a decline in physical reserve and strength), your doctor will track your weight and nutrition, and they may perform physical tests—like checking your grip strength or timing how easily you can stand from a chair [8][9].
Mental Health: Anxiety and Depression
Coping with a chronic illness and struggling to breathe can take a significant emotional toll. Anxiety and depression are very common in people with COPD but are frequently underdiagnosed [10]. These conditions are associated with a lower quality of life, decreased physical activity, more frequent flare-ups, and difficulty sticking to treatment plans [10]. Your care team should proactively ask about your mood, and you should feel empowered to bring it up. Support options can include counseling, pulmonary rehabilitation, or medication reviews.
(If you ever experience severe depression or thoughts of self-harm, seek immediate emergency crisis help).
Sleep Apnea (COPD-OSA Overlap Syndrome)
Obstructive sleep apnea (OSA) involves repeated pauses in breathing during sleep. Having both conditions is called COPD-OSA overlap syndrome, which can significantly impact your health [11]. Your doctor may use a screening questionnaire, like the STOP-Bang tool, to evaluate your risk [12]. They will ask about signs like loud snoring, waking up gasping, morning headaches, daytime sleepiness, and obesity—though sleep apnea can sometimes occur without obvious daytime sleepiness or excess weight [13]. Questionnaires do not diagnose sleep apnea; if suspected, an overnight sleep study (often an attended in-lab polysomnogram for those with COPD) is required to confirm it [14].
Lung Cancer Risk
Both a history of smoking and having COPD itself increase your risk of developing lung cancer [15]. Your doctor should discuss whether you are a candidate for a low-dose computed tomography (LDCT) scan. This is a periodic screening test designed for people without symptoms [16].
Eligibility criteria depend on local guidelines but typically require you to be a certain age (e.g., 50 to 80 years old), to currently smoke or have quit within the last 15 years, and to have a significant smoking history measured in “pack-years” (the number of packs smoked per day multiplied by the number of years smoked) [17]. Screening requires shared decision-making: you and your doctor will weigh the risk of false positives, the potential need for invasive follow-up testing, and whether your overall health would allow for potentially curative treatments if a nodule is found [18][16]. (Note: If you have active symptoms like coughing blood or unexplained weight loss, you need diagnostic testing, not routine screening).
Pulmonary Hypertension
Pulmonary hypertension is high blood pressure in the arteries of your lungs, which can sometimes complicate severe COPD or overlap syndrome [11]. If your shortness of breath or low oxygen levels are far worse than expected based on your lung function tests, your doctor may investigate further [19]. An echocardiogram can help estimate pressures, but a right-heart catheterization—a procedure where a thin tube is threaded into the heart and lung vessels to directly measure pressures—is required to officially confirm the diagnosis [20].
Medications and Vaccinations
A crucial part of any COPD checkup is reviewing your current treatments to make sure they are safe, effective, and correctly used.
- Medication & Oxygen Review: Your doctor should periodically check your inhaler technique [21]. They will also determine if medications like inhaled corticosteroids (ICS) are appropriate for you based on your history of flare-ups and specific blood tests (like eosinophil counts) [22][23]. If you use home oxygen, your needs should be reassessed using resting or exertional oxygen measurements [24]. Safety Warning: Never stop or adjust your oxygen or inhalers without your doctor’s explicit instructions. If you use oxygen, follow strict fire safety rules—never smoke or allow open flames nearby.
- Vaccinations: Preventing infections is vital to avoiding COPD flare-ups. You will not need every vaccine at every visit. Recommendations depend on your age, prior doses, immune status, and current local guidelines [25]. This generally includes an annual influenza (flu) shot, plus periodic or one-time vaccines for pneumococcal pneumonia, RSV, COVID-19, pertussis (whooping cough), and shingles [25][26].
(Note: This list is not exhaustive. Depending on your symptoms, your doctor may also evaluate you for anemia, acid reflux, bronchiectasis, kidney disease, or diabetes).
Before Your Visit Checklist
To get the most out of your checkup, bring the following to your appointment:
- An updated list of all medications and supplements
- Your vaccination record
- Notes on any recent flare-ups, urgent care visits, or steroid courses
- Your exact smoking history (pack-years and quit date, if applicable)
- Notes on any changes in your weight, sleep quality, mood, exercise tolerance, or home oxygen readings
Common questions in this guide
What other conditions should be considered during a COPD checkup?
Do I need heart tests if I have COPD?
How does COPD affect bone and muscle screening?
How is sleep apnea checked in people with COPD?
Can I get a low-dose CT scan for lung cancer because I have COPD?
What COPD symptoms mean I should seek urgent care?
What should be reviewed at a routine COPD checkup?
Appointments are short. Make every minute count.
Specialist visits move fast. Let us help you prep so your time goes to what matters.
Screening at checkups
Could my checkup include screening for heart disease or sleep apnea?
About testing
Do I need tests like an ECG or sleep study at every checkup?
Mood and emotional health
How will my care team check my mood during COPD checkups?
Related questions
Show more
Get notified when new evidence is published on chronic obstructive pulmonary disease.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (26)
- 1
Assessing Symptom Burden.
Vogelmeier CF, Alter P
Clinics in chest medicine 2020; (41(3)):367-373 doi:10.1016/j.ccm.2020.06.005.
PMID: 32800191 - 2
Co-morbidities in 99 COPD patients: A case series from Syria.
Mohammad Y, Yassine F, Khadouj M
Journal of translational internal medicine 2015; (3(4)):167-170 doi:10.1515/jtim-2015-0029.
PMID: 27847908 - 3
Heart failure and chronic obstructive pulmonary disease: a review.
Horodinschi RN, Bratu OG, Dediu GN, et al.
Acta cardiologica 2020; (75(2)):97-104 doi:10.1080/00015385.2018.1559485.
PMID: 30650022 - 4
Identification and management of cardiopulmonary risk in patients with chronic obstructive pulmonary disease: a multidisciplinary consensus and modified Delphi study.
Gale CP, Hurst JR, Hawkins NM, et al.
European journal of preventive cardiology 2025; (32(15)):1445-1460 doi:10.1093/eurjpc/zwaf119.
PMID: 40037333 - 5
Multidisciplinary Management of Patients With Chronic Obstructive Pulmonary Disease and Cardiovascular Disease.
de Miguel-Díez J, Núñez Villota J, Santos Pérez S, et al.
Archivos de bronconeumologia 2024; (60(4)):226-237 doi:10.1016/j.arbres.2024.01.013.
PMID: 38383272 - 6
Cardiac dysfunction in exacerbations of chronic obstructive pulmonary disease is often not detected by electrocardiogram and chest radiographs.
Shafuddin E, Chang CL, Cooray M, et al.
Internal medicine journal 2019; (49(6)):761-769 doi:10.1111/imj.14144.
PMID: 30324703 - 7
COPD and osteoporosis: links, risks, and treatment challenges.
Inoue D, Watanabe R, Okazaki R
International journal of chronic obstructive pulmonary disease 2016; (11()):637-48 doi:10.2147/COPD.S79638.
PMID: 27099481 - 8
Sarcopenia as a treatable trait in COPD: From mechanisms to management.
Matera MG, Page C, Cazzola M
Respiratory medicine 2025; (248()):108401 doi:10.1016/j.rmed.2025.108401.
PMID: 41057104 - 9
Practical Guidelines by the Andalusian Group for Nutrition Reflection and Investigation (GARIN) on Nutritional Management of Patients with Chronic Obstructive Pulmonary Disease: A Review.
Justel Enríquez A, Rabat-Restrepo JM, Vilchez-López FJ, et al.
Nutrients 2024; (16(18)) doi:10.3390/nu16183105.
PMID: 39339705 - 10
Prevalence, Contribution to Disease Burden and Management of Comorbid Depression and Anxiety in Chronic Obstructive Pulmonary Disease: A Narrative Review.
Zareifopoulos N, Bellou A, Spiropoulou A, Spiropoulos K
COPD 2019; (16(5-6)):406-417 doi:10.1080/15412555.2019.1679102.
PMID: 31638445 - 11
Impact of obstructive sleep apnea on pulmonary hypertension in patients with chronic obstructive pulmonary disease.
Sun WL, Wang JL, Jia GH, et al.
Chinese medical journal 2019; (132(11)):1272-1282 doi:10.1097/CM9.0000000000000247.
PMID: 30973448 - 12
The Screening Value Of ESS, SACS, BQ, And SBQ On Obstructive Sleep Apnea In Patients With Chronic Obstructive Pulmonary Disease.
Xiong M, Hu W, Dong M, et al.
International journal of chronic obstructive pulmonary disease 2019; (14()):2497-2505 doi:10.2147/COPD.S223354.
PMID: 32009782 - 13
Prevalence and Predictors of Obstructive Sleep Apnea in Patients with Chronic Obstructive Pulmonary Disease Undergoing Inpatient Pulmonary Rehabilitation.
Schreiber A, Cemmi F, Ambrosino N, et al.
COPD 2018; (15(3)):265-270 doi:10.1080/15412555.2018.1500533.
PMID: 30239226 - 14
Sleep disordered breathing: OSA-COPD overlap.
van Zeller M, McNicholas WT
Expert review of respiratory medicine 2024; (18(6)):369-379 doi:10.1080/17476348.2024.2373790.
PMID: 38932721 - 15
Airflow Limitation and Histology Shift in the National Lung Screening Trial. The NLST-ACRIN Cohort Substudy.
Young RP, Duan F, Chiles C, et al.
American journal of respiratory and critical care medicine 2015; (192(9)):1060-7 doi:10.1164/rccm.201505-0894OC.
PMID: 26199983 - 16
Lung Cancer Screening in Patients with COPD-A Case Report.
Amirahmadi R, Kumar AJ, Cowan M, Deepak J
Medicina (Kaunas, Lithuania) 2019; (55(7)) doi:10.3390/medicina55070364.
PMID: 31336732 - 17
Sleep disordered breathing and nocturnal hypoxemia are very prevalent in a lung cancer screening population and may condition lung cancer screening findings: results of the prospective Sleep Apnea In Lung Cancer Screening (SAILS) study.
Pérez-Warnisher MT, Cabezas E, Troncoso MF, et al.
Sleep medicine 2019; (54()):181-186 doi:10.1016/j.sleep.2018.10.020.
PMID: 30580192 - 18
Lung cancer screening in patients with chronic obstructive pulmonary disease.
Gonzalez J, Marín M, Sánchez-Salcedo P, Zulueta JJ
Annals of translational medicine 2016; (4(8)):160 doi:10.21037/atm.2016.03.57.
PMID: 27195278 - 19
Severe pulmonary hypertension in chronic obstructive pulmonary disease - From clinical perspective to histological evidence.
Zeder K, Sassmann T, Foris V, et al.
International journal of cardiology. Congenital heart disease 2024; (17()):100519 doi:10.1016/j.ijcchd.2024.100519.
PMID: 39711774 - 20
Management of Pulmonary Hypertension Associated with Chronic Lung Disease.
Blanco I, Hernández-González F, García A, et al.
Seminars in respiratory and critical care medicine 2023; (44(6)):826-839 doi:10.1055/s-0043-1770121.
PMID: 37487524 - 21
Personalizing Selection of Inhaled Delivery Systems in Chronic Obstructive Pulmonary Disease.
Mahler DA, Halpin DMG
Annals of the American Thoracic Society 2023; (20(10)):1389-1396 doi:10.1513/AnnalsATS.202304-384CME.
PMID: 37499210 - 22
Individual trajectory-based care for COPD: getting closer, but not there yet.
Roche N, Devillier P, Berger P, et al.
ERJ open research 2021; (7(4)) doi:10.1183/23120541.00451-2021.
PMID: 34912881 - 23
A Cross-Sectional Study Assessing Appropriateness Of Inhaled Corticosteroid Treatment In Primary And Secondary Care Patients With COPD In Sweden.
Sulku J, Janson C, Melhus H, et al.
International journal of chronic obstructive pulmonary disease 2019; (14()):2451-2460 doi:10.2147/COPD.S218747.
PMID: 31806954 - 24
The benefits and drawbacks of home oxygen therapy for COPD: what's next?
Khor YH, Ekström M
Expert review of respiratory medicine 2024; (18(7)):469-483 doi:10.1080/17476348.2024.2379459.
PMID: 38984511 - 25
Vaccination in Chronic Obstructive Pulmonary Disease.
Kwok WC, Wong JC, Cheung A, Tam TC
Vaccines 2025; (13(3)) doi:10.3390/vaccines13030218.
PMID: 40266071 - 26
Role of Vaccination in the Prevention of ECOPD.
Sartori F, Crisafulli E, Cariqueo M, et al.
Seminars in respiratory and critical care medicine 2026; (47(3)):323-333 doi:10.1055/a-2837-8778.
PMID: 41871621
This page is for informational purposes only and does not constitute medical advice. Your COPD clinician should decide which comorbidities and tests are appropriate based on your symptoms, risks, and overall health.